Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System
Tumors of the digestive system, when combined together, account for more new cases and deaths per year than tumors arising in any other system of the body and their incidence continues to increase. Despite major efforts aimed at discovering and validating novel and effective drugs against these mali...
Main Authors: | Federica Laudisi, Martin Marônek, Antonio Di Grazia, Giovanni Monteleone, Carmine Stolfi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/14/4957 |
Similar Items
-
Double Repositioning: Veterinary Antiparasitic to Human Anticancer
by: Tania Sultana, et al.
Published: (2022-04-01) -
Repurposing of Benzimidazole Anthelmintic Drugs as Cancer Therapeutics
by: Bomi Song, et al.
Published: (2022-09-01) -
Anthelmintic Drugs as Emerging Immune Modulators in Cancer
by: Carmine Stolfi, et al.
Published: (2023-03-01) -
Viruses in Cancers of the Digestive System: Active Contributors or Idle Bystanders?
by: Martin Marônek, et al.
Published: (2020-10-01) -
Salicylanilides and Their Anticancer Properties
by: Tereza Kauerová, et al.
Published: (2023-01-01)